Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$73.76 n/a | n/a%
07/21/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 73.76
52 Week High 88.85
52 Week Low 63.76
Avg. Daily Vol. (Mil) 8.65
Beta (3 year) 0.97
Share Related Items
Mkt Cap (Mil) 96,384.29
Shares Out (Mil) 1,306.73
Float (Mil) 1,298.94
Dividend Information
Yield % 2.80
Annual Dividend 2.08
Payout Ratio 20.00
Financial Strength
Quick Ratio 1.80
Current Ratio 2.20
LT Debt/ Equity 1.39
Total Debt / Equity 1.39
Valuation Ratios
Price Earnings 7.80
Price/Sales 3.31
Price/Book 5.10
Price/Cash Flow 6.60
Per Share Data
Earnings 9.47
Sales 22.27
Book Value 14.45
Cash Flow 11.21
Business Summary
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
General Information
333 Lakeside Drive
Foster City, CA 94404
Industry : Drugs
Sector: Health Care
Employees: 9000
CEO: Dr. John F. Milligan, PhD
Short Interest
Current Month (Mil) 13.66
Previous Month (Mil) 11.80
Short Interest Ratio (Days) 1.30
Management Effectiveness
Return on Equity 71.40
Return on Assets 23.70
Return on Investments 29.80
Gross Margin 89.80
EBIT Margin 59.40
Profit Margin 43.40

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter